Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Holdings Lifted by Natixis

Natixis lifted its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 36.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,426 shares of the company’s stock after acquiring an additional 6,001 shares during the period. Natixis’ holdings […]

Related Keywords

United States ,Canada ,America ,Garya Lyons ,Robertw Baird ,Darin Lippoldt ,Neurocrine Biosciences ,Nasdaq ,Exchange Commission ,Jpmorgan Chase Co ,Neurocrine Biosciences Inc ,Covestor Ltd ,Bessemer Group Inc ,Kb Financial Partners ,Securities Exchange Commission ,Acadian Asset Management ,Royal Bank ,Free Report ,Asset Management ,Spire Wealth Management ,Wealth Management ,Director Gary ,Get Free Report ,Visit Holdingschannel ,Neurocrine Biosciences Daily ,Nasdaq Nbix ,Nbix ,Medical ,64125c10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,